Your text here
Running head: IMMUNIZATION CASE STUDY 1
Week 3: Immunization Case
Study BSN RN
Chamberlain University
, IMMUNIZATION CASE STUDY 2
Week 3: Immunization Case Study
The purpose of this assignment is to explore and identify vaccines available in the United
States for preventable diseases, understanding contraindications, precautions and
recommendations from the Advisory Committee on Immunization Practice (ACIP). This paper
will discuss 4 case studies related to childhood immunizations.
Case Study 1
The first admission is a term newborn at 3.5 kg with normal labs and normal infant exam.
The recommended vaccine that the newborn should receive is the Hepatitis B (Hep B) vaccine
within the first 24 hours (CDC, 2019a). The 3-dose series should be initiated with a single dose
antigen Hep B only as the first dose. The final dose should not be given before the baby reaches
24 weeks old (CDC, 2019a). This vaccine protects from Hep B and others positive with the
disease, because children who have Hep B do not present with signs or symptoms. This vaccine
also prevents the child from developing liver disease or cancers stemming from Hep B (CDC,
2019a).
If mother was tested positive for Hep B there are other precautions that must be taken to
protect the child. The recommended Hep B vaccine would still be administered as well as the
Hepatitis B Immunoglobulin (HBIG) would be given within the first 12 hours of birth (CDC,
2019a). These injections would be administered at two different locations (separate extremities).
A serologic test for anti-HB + HBsAg after the completion of the vaccine series between 9-12
months or during the next well visit after series is complete. Do not attempt serologic testing
prior to 9 months because it may indicate passive anti-HB and HBIG administered from birth
(CDC, 2019a). If the child comes back negative for their follow up serologic testing and the anti-
HB level is ≤ 10 mIU/mL, then the child is protected and does not need further management. If
Running head: IMMUNIZATION CASE STUDY 1
Week 3: Immunization Case
Study BSN RN
Chamberlain University
, IMMUNIZATION CASE STUDY 2
Week 3: Immunization Case Study
The purpose of this assignment is to explore and identify vaccines available in the United
States for preventable diseases, understanding contraindications, precautions and
recommendations from the Advisory Committee on Immunization Practice (ACIP). This paper
will discuss 4 case studies related to childhood immunizations.
Case Study 1
The first admission is a term newborn at 3.5 kg with normal labs and normal infant exam.
The recommended vaccine that the newborn should receive is the Hepatitis B (Hep B) vaccine
within the first 24 hours (CDC, 2019a). The 3-dose series should be initiated with a single dose
antigen Hep B only as the first dose. The final dose should not be given before the baby reaches
24 weeks old (CDC, 2019a). This vaccine protects from Hep B and others positive with the
disease, because children who have Hep B do not present with signs or symptoms. This vaccine
also prevents the child from developing liver disease or cancers stemming from Hep B (CDC,
2019a).
If mother was tested positive for Hep B there are other precautions that must be taken to
protect the child. The recommended Hep B vaccine would still be administered as well as the
Hepatitis B Immunoglobulin (HBIG) would be given within the first 12 hours of birth (CDC,
2019a). These injections would be administered at two different locations (separate extremities).
A serologic test for anti-HB + HBsAg after the completion of the vaccine series between 9-12
months or during the next well visit after series is complete. Do not attempt serologic testing
prior to 9 months because it may indicate passive anti-HB and HBIG administered from birth
(CDC, 2019a). If the child comes back negative for their follow up serologic testing and the anti-
HB level is ≤ 10 mIU/mL, then the child is protected and does not need further management. If
